AzTrials
AzTrials

Massive Rotator Cuff TearROTATORCUFFNCT07375277

Effects Of Biceps Transposition Without Tenotomy For Augmentation Of Massive Rotator Cuff Repairs

A study testing LHBT Transposition Augmentation in people with Massive Rotator Cuff Tear, run by Balikesir Ataturk City Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective, single-arm interventional study will evaluate the effects of long head of the biceps tendon (LHBT) transposition without tenotomy as an augmentation technique for arthroscopic partial repair in adults with massive rotator cuff tears. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Massive Rotator Cuff Tear
What is being tested?
LHBT Transposition Augmentation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
35 participants
Where
1 siteTurkey (Türkiye)
Study dates
26 Mar 2026to 15 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older
  • Diagnosis of a massive rotator cuff tear on preoperative MRI, defined as a full-thickness tear involving at least two tendons and/or a tear with a greatest dimension greater than 5 cm
  • Planned arthroscopic partial rotator cuff repair with augmentation using tenotomy-sparing long head of the biceps tendon (LHBT) transposition
  • Persistence of symptoms despite at least 3 months of standard nonoperative treatment
  • Intact LHBT confirmed intraoperatively
  • Willingness and ability to attend scheduled follow-up visits (baseline, 3 months, and 12 months)
  • Provision of written informed consent

Who cannot join

  • Tear patterns not requiring augmentation (e.g., preserved rotator cable patterns)
  • Neurologic conditions, inflammatory arthritis, active infection, or systemic conditions that may affect shoulder function or prevent protocol rehabilitation
  • Inability to provide informed consent
  • Expected nonadherence to follow-up or rehabilitation protocol

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

gunes SARIKAYA contact

05436733113

Turkey (Türkiye)1 site, 1 recruiting
  • Güneş Sarıkaya

    Balıkesir

    güneş sarıkaya

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Effects Of Biceps Transposition Without Tenotomy For Augmentation Of Massive Rotator Cuff Repairs On Function, Quality Of Life, And Sleep: A Prospective Study

This prospective, single-arm interventional study will evaluate the effects of long head of the biceps tendon (LHBT) transposition without tenotomy as an augmentation technique for arthroscopic partial repair in adults with massive rotator cuff tears. Consecutive eligible patients undergoing arthroscopic partial rotator cuff repair plus tenotomy-sparing LHBT transposition augmentation at Balikesir City Hospital (Balikesir, Turkiye) will be enrolled and followed for 12 months. Patient-reported outcomes and clinical assessments will be collected preoperatively (baseline) and postoperatively at 3 and 12 months. The primary outcomes are shoulder function (ASES), rotator cuff-related quality of life (WORC converted to a 0-100 scale), and sleep disturbance (Insomnia Severity Index). Secondary outcomes include active shoulder range of motion and biceps-related clinical findings (Speed test, Yergason test, bicipital groove tenderness, and Popeye deformity). Postoperative MRI will not be obtained routinely and will be performed only if clinically indicated. The study aims to provide standardized prospective data on functional outcomes, quality of life, and sleep after this augmentation approach.

Read the detailed description

Detailed Description Massive rotator cuff tears may not be amenable to full anatomic repair, and even when partial repair is feasible, residual symptoms and functional limitations may persist. Long head of the biceps tendon (LHBT) transposition without tenotomy has been proposed as an augmentation strategy that may provide additional biomechanical and biologic support to arthroscopic partial rotator cuff repair. However, prospective data with standardized follow-up evaluating functional outcomes, rotator cuff-specific quality of life, and sleep outcomes remain limited. This study is designed to generate prospective, standardized clinical and patient-reported outcome data after tenotomy-sparing LHBT transposition augmentation in the setting of massive rotator cuff repair.

This is a prospective, single-arm, non-randomized interventional clinical study conducted at Balikesir City Hospital, Department of Orthopedics and Traumatology (Balikesir, Turkiye). Consecutive eligible adult patients will be enrolled between January 2026 and December 2026, with a planned sample size of 35 participants. Each participant will be followed for a minimum of 12 months. Assessments will be performed preoperatively (baseline) and postoperatively at 3 months and 12 months.

Participants and Eligibility Massive rotator cuff tear will be defined on preoperative MRI as a full-thickness tear involving at least two tendons and/or a tear with the greatest dimension greater than 5 cm. Final eligibility will be confirmed intraoperatively when the tear pattern is deemed suitable for arthroscopic partial repair with LHBT augmentation. Inclusion criteria include age 18 years or older, persistence of symptoms despite at least 3 months of standard nonoperative treatment, planned arthroscopic partial repair with LHBT augmentation, intact LHBT at the time of surgery, and willingness to attend the scheduled follow-up visits. Exclusion criteria include tear patterns not requiring augmentation (e.g., preserved rotator cable patterns), conditions affecting shoulder function (e.g., relevant neurologic disease, inflammatory arthritis), active infection, systemic conditions preventing protocol rehabilitation, inability to provide informed consent, or expected nonadherence to follow-up.

Intervention and Standardization All surgeries will be performed arthroscopically under general anesthesia (with or without interscalene block per anesthesia protocol) in the beach-chair position. Standard diagnostic glenohumeral assessment and subacromial bursectomy will be performed. Acromioplasty may be performed routinely per the surgical standard. The rotator cuff will be mobilized and partially repaired to achieve acceptable tension. For augmentation, the LHBT will be confirmed intact and will not be tenotomized. The transverse humeral ligament will be released to mobilize the tendon. The tendon will be transposed posterior to the bicipital groove and directed to the superior aspect of the greater tuberosity, avoiding overtension. Fixation will be performed to the footprint region using a standardized anchor/suture technique to create an augmentation construct supporting the partial repair. Arthroscopic assessment will confirm absence of overtension and mechanical impingement. Concomitant procedures (e.g., subscapularis repair, distal clavicle resection) will be performed only when clinically indicated and will be recorded.

Rehabilitation Protocol Postoperative management will be standardized: sling immobilization for 3 weeks; passive range of motion initiated immediately in the early postoperative period within pain limits; active range of motion starting at postoperative week 4; strengthening at approximately postoperative month 3. Biceps loading will be restricted for the first 4 weeks (no resisted elbow flexion or supination), followed by gradual progression. Rehabilitation adherence and protocol deviations will be documented.

Imaging and Intraoperative Measurements Preoperative MRI will be evaluated using the Patte classification (retraction) and Goutallier grading (fatty degeneration) by two independent assessors, with disagreements resolved by consensus. Preoperative radiographs will include Hamada classification and acromiohumeral interval (mm). Intraoperatively, tear dimensions (anteroposterior and mediolateral) will be measured using a calibrated probe at the footprint level; tear area will be recorded using a standardized practical approach (e.g., AP × ML). Routine postoperative MRI will not be performed and will be obtained only if clinically indicated (e.g., sudden strength loss, trauma, suspected failure).

Outcomes Primary outcomes are changes in ASES score, WORC score (reported on a 0-100 scale), and Insomnia Severity Index (ISI) from baseline to 3 and 12 months. WORC will be converted to a 0-100 scale using the formula: WORC (0-100) = [1 - (raw WORC / 2100)] × 100, where higher scores indicate better status. Secondary outcomes include active shoulder range of motion (forward elevation, abduction, external rotation by goniometer; internal rotation recorded using a standard method) and biceps-related clinical findings (Speed test, Yergason test, bicipital groove tenderness, Popeye deformity) assessed at baseline, 3 months, and 12 months.

Safety, Data Management, and Analysis All adverse events and complications will be recorded throughout follow-up, and clinically indicated standard care will be provided when needed. Participant data will be de-identified using unique study IDs and stored in password-protected, access-restricted electronic files. Data quality will be supported by random source verification of approximately 10% of records. Statistical analyses will use two-sided significance level of p < 0.05. Longitudinal changes across time points (baseline, 3 months, 12 months) will be analyzed using linear mixed-effects models (time as fixed effect; participant as random intercept), with appropriate adjustment for multiple comparisons (e.g., Holm-Bonferroni). If assumptions are violated, nonparametric repeated-measures methods will be used as sensitivity analyses. Binary outcomes will be analyzed using appropriate paired/repeated methods (e.g., McNemar for two time points; mixed-effects logistic regression for three time points). Effect sizes and 95% confidence intervals will be reported, and missing data patterns will be described with complete-case sensitivity analyses.

Being tested
LHBT Transposition Augmentation
Keywords
Biceps Transposition, Massive Rotator Cuff Tear, Arthroscopic Partial Repair

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LHBT Transposition AugmentationProcedure or surgery

    Arthroscopic partial rotator cuff repair augmented with transposition of the intact long head of the biceps tendon (LHBT) without tenotomy. The transverse humeral ligament is released to mobilize the tendon, which is transposed and fixed to the greater tuberosity footprint using a standardized anchor/suture technique to support the partial repair. Procedures are performed under a standardized surgical and postoperative rehabilitation protocol.

Study groups in NCT07375277
Study groupRoleWhat they receive
Biceps Transposition AugmentationOtherParticipants in this single arm undergo arthroscopic partial rotator cuff repair augmented with tenotomy-sparing transposition of the long head of the biceps tendon (LHBT). All procedures are performed according to a standardized surgical and rehabilitation protocol.
Receives: Procedure: LHBT Transposition Augmentation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. American Shoulder and Elbow Surgeons (ASES) Score

    The ASES score is a validated patient-reported outcome measure assessing shoulder pain and function on a 0-100 scale, with higher scores indicating better shoulder function.

    Measured: aseline, 3 months, and 12 months postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2026
  2. Study start26 Mar 2026
  3. Primary completion15 Dec 2027 (estimated)
  4. Study completion15 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Single-arm, single-group study in which all participants undergo arthroscopic partial rotator cuff repair augmented with tenotomy-sparing long head of the biceps tendon (LHBT) transposition, with outcomes assessed at baseline, 3 months, and 12 months.
Masking
None (open label)
Enrolment
35 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07375277
Sponsor's protocol ID
BCH-BTA-MRCR-2026-001
Acronym
ROTATORCUFF
Status last verified
Aug 2026
First submitted
17 Jan 2026
Last updated
31 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing LHBT Transposition Augmentation in people with Massive Rotator Cuff Tear, run by Balikesir Ataturk City Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 31 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact gunes 0 SARIKAYA, M.D (05436733113 ext. 0, gunessarikaya05@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

American Shoulder and Elbow Surgeons (ASES) Score (time frame: aseline, 3 months, and 12 months postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in